Seth A. Freedman

Patent Agent

+1 617 646 1628 +1 617 646 1628
seth.freedman@finnegan.com seth.freedman@finnegan.com

Two Seaport Lane
Boston, MA 02210-2001

vCard

Show Seth's work in

Seth Freedman utilizes his academic and industrial experience in natural product total synthesis and medicinal chemistry to assist clients with patent prosecution matters in the chemical and pharmaceutical fields.

Prior to joining Finnegan, Seth developed expertise in chemistry during his graduate studies, through which he earned a masters degree performing research on novel cyclization methodology utilizing gold(I) catalysis. This work included developing synthetic routes towards quaternary center-rich and non-functionalized terpene natural products.

While pursuing his undergraduate degree, Seth performed research on the total synthesis of the stereochemically rich polyketide family of phomopsolide natural products. This work also included S-SAR studies on the natural product family along with unnatural analogues synthesized in the lab. Seth gained experience in the drug discovery industry by engaging in two co-op internship opportunities in the biotechnology and pharmaceutical industries, specializing in the small molecule space.

Et Cetera

Recipient, National Science Foundation Graduate Research Fellowship, 2023.
Coauthor. "Ketoreductase-Catalyzed Access to Axially Chiral 2,6-Disubstituted Spiro[3.3]heptane Derivatives," Organic Letters, 2022.
Coauthor. "Synthesis and Direct Comparison of the Anticancer Activities of Phomopsolides D/E and Two 7-Oxa-/7-Aza-analogues," Medicinal Chemistry Communications, 2020.
Coauthor. "Asymmetric Synthesis of 7-Aza-phomopsolide E and its C-4 Epimer," Tetrahedron, 2018.

Experience

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Professional Activities

American Chemical Society
(member)

Admissions and Education

Admissions

U.S. Patent and Trademark Office

Education

University of Chicago: M.S., Chemistry, 2022

Northeastern University: B.S., Chemistry, 2021

Seth's Practices

Prosecution and Portfolio Management: IP Portfolio Management; Patent Drafting and Prosecution

Seth's Industries

Chemicals, Industrials, and Materials: Chemical
Life Sciences: Biotechnology; Pharmaceutical